Published: May 29th, 2018
Published: Oct 13th, 2017
As an autoimmune disease, Type 1 diabetes has long been thought to result from a complete immune system killing of the insulin-producing beta cells within the pancreas. Now, University of […]
Published: Dec 6th, 2015
UFDI Director Mark Atkinson, Ph.D. and collaborators found that GABA is rapidly absorbed and tolerated in human beings. They believe that its endocrine effects suggest potential therapeutic benefits for diabetes.
Published: Nov 21st, 2015
UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet […]
Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice
Published: Nov 20th, 2015
UFDI researchers Amanda Posgai, Ph.D. and Mark Atkinson, Ph.D. and collaborators examine a new approach for preserving beta cell function in patients with recent onset T1D.
Published: Nov 12th, 2015
UFDI Researcher Mark Atkinson, Ph.D. and collaborators found that that GABA is rapidly absorbed and tolerated in human beings, and its endocrine effects suggest potential therapeutic benefits for diabetes.
Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β
Published: Nov 9th, 2015
Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting […]
Published: Oct 20th, 2015
UFDI Director Mark Atkinson, Ph.D. and Insulin for Life found a way to recycle unused diabetes supplies.
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes
Published: Oct 18th, 2015
UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]
Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Published: Oct 12th, 2015
UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.